Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Safety of computed tomography in patients with cardiac rhythm management devices: assessment of the U.S. Food and Drug Administration advisory in clinical practice.

Hussein AA, Abutaleb A, Jeudy J, Phelan T, Patel R, Shkullaku M, Siddiqi F, See V, Saliaris A, Shorofsky SR, Dickfeld T.

J Am Coll Cardiol. 2014 May 6;63(17):1769-75. doi: 10.1016/j.jacc.2013.12.040. Epub 2014 Feb 26.

2.

Cardiac rhythm management devices: when regulatory agencies "over-regulate".

Arbelo E, Brugada J.

J Am Coll Cardiol. 2014 May 6;63(17):1776-7. doi: 10.1016/j.jacc.2014.01.043. Epub 2014 Feb 26. No abstract available.

3.

Effect of computed tomography imaging on rhythm devices in real-world practice.

Donnino R, Srichai MB, Madan VD, Bernstein SA, Jacobs JE.

J Am Coll Cardiol. 2014 Dec 2;64(21):2301-2. doi: 10.1016/j.jacc.2014.03.065. Epub 2014 Nov 24. No abstract available.

4.

Reply: Effect of computed tomography imaging on rhythm devices in real-world practice.

Hussein A, Abutaleb A, Jeudy J, Phelan T, Patel R, Shkullaku M, Siddiqi F, See V, Saliaris A, Shorofsky SR, Dickfeld T.

J Am Coll Cardiol. 2014 Dec 2;64(21):2302-3. doi: 10.1016/j.jacc.2014.04.092. Epub 2014 Nov 24. No abstract available.

5.

Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators.

Maisel WH, Sweeney MO, Stevenson WG, Ellison KE, Epstein LM.

JAMA. 2001 Aug 15;286(7):793-9.

PMID:
11497532
6.

Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.

Powell BD, Saxon LA, Boehmer JP, Day JD, Gilliam FR 3rd, Heidenreich PA, Jones PW, Rousseau MJ, Hayes DL.

J Am Coll Cardiol. 2013 Oct 29;62(18):1674-9. doi: 10.1016/j.jacc.2013.04.083. Epub 2013 Jun 27.

7.

An analysis of implantable cardiac device reliability. The case for improved postmarketing risk assessment and surveillance.

Laskey W, Awad K, Lum J, Skodacek K, Zimmerman B, Selzman K, Zuckerman B.

Am J Ther. 2012 Jul;19(4):248-54. doi: 10.1097/MJT.0b013e3182512ca5.

PMID:
22668602
8.

Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports.

Maisel WH, Moynahan M, Zuckerman BD, Gross TP, Tovar OH, Tillman DB, Schultz DB.

JAMA. 2006 Apr 26;295(16):1901-6.

PMID:
16639048
9.

Determining the risks of magnetic resonance imaging at 1.5 tesla for patients with pacemakers and implantable cardioverter defibrillators.

Cohen JD, Costa HS, Russo RJ.

Am J Cardiol. 2012 Dec 1;110(11):1631-6. doi: 10.1016/j.amjcard.2012.07.030. Epub 2012 Aug 23.

PMID:
22921995
10.

FDA approval of cardiac implantable electronic devices via original and supplement premarket approval pathways, 1979-2012.

Rome BN, Kramer DB, Kesselheim AS.

JAMA. 2014 Jan 22-29;311(4):385-91. doi: 10.1001/jama.2013.284986.

11.

Deaths and cardiovascular injuries due to device-assisted implantable cardioverter-defibrillator and pacemaker lead extraction.

Hauser RG, Katsiyiannis WT, Gornick CC, Almquist AK, Kallinen LM.

Europace. 2010 Mar;12(3):395-401. doi: 10.1093/europace/eup375. Epub 2009 Nov 27.

12.

Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).

Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S.

Circulation. 2007 May 8;115(18):2382-9. Epub 2007 Apr 30.

13.

Management of recalled pacemakers and implantable cardioverter-defibrillators: a decision analysis model.

Amin MS, Matchar DB, Wood MA, Ellenbogen KA.

JAMA. 2006 Jul 26;296(4):412-20.

PMID:
16868299
14.

Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices.

Samii SM.

Med Clin North Am. 2015 Jul;99(4):795-804. doi: 10.1016/j.mcna.2015.02.008. Review.

PMID:
26042883
15.

A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post-(MRI).

Burke PT, Ghanbari H, Alexander PB, Shaw MK, Daccarett M, Machado C.

J Interv Card Electrophysiol. 2010 Jun;28(1):59-66. doi: 10.1007/s10840-009-9463-y. Epub 2010 Jan 29.

PMID:
20111895
16.

Changing trends in pacemaker and implantable cardioverter defibrillator generator advisories.

Maisel WH, Stevenson WG, Epstein LM.

Pacing Clin Electrophysiol. 2002 Dec;25(12):1670-8.

PMID:
12520666
17.

Practice advisory for the perioperative management of patients with cardiac rhythm management devices: pacemakers and implantable cardioverter-defibrillators: a report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices.

American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Cardiac Rhythm Management Devices.

Anesthesiology. 2005 Jul;103(1):186-98. Review. No abstract available.

PMID:
15983472
18.

How are arrhythmias detected by implanted cardiac devices managed in Europe? Results of the European Heart Rhythm Association Survey.

Todd D, Hernandez-Madrid A, Proclemer A, Bongiorni MG, Estner H, Blomström-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association.

Europace. 2015 Sep;17(9):1449-53. doi: 10.1093/europace/euv310.

PMID:
26443791
19.

Complications of permanent cardiac pacing in patients with persistent left superior vena cava.

Polewczyk A, Kutarski A, Czekajska-Chehab E, Adamczyk P, Boczar K, Polewczyk M, Janion M.

Cardiol J. 2014;21(2):128-37. doi: 10.5603/CJ.a2014.0006. Epub 2014 Feb 14.

PMID:
24526508
20.

Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.

Alam MB, Munir MB, Rattan R, Flanigan S, Adelstein E, Jain S, Saba S.

Europace. 2014 Feb;16(2):246-51. doi: 10.1093/europace/eut301. Epub 2013 Oct 6.

PMID:
24099864

Supplemental Content

Support Center